Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 1049
54. Hess , H. , and Janssen , H. J. ( 1969 ), Lacquered tablets and fi lm coated tablets, Pharm .
Acta Helv. , 44 , 581 .
55. Bindsch ä dler , C. , Gurny , R. , and Dolker , B. ( 1983 ), Theoretical concepts regarding the
formation of fi lms from aqueous microdispersions and application to coating, Labo -
Pharma , Probl. Tech. , 31 , 389 – 394 .
56. Radebaugh , G. W. ( 1990 – 1996 ), Film coating and fi lm - forming materials: Evaluation ,
in Swarbrick , J. , and Boylan , J. C. , Eds., Encyclopedia of Pharmaceutical Technology ,
Vol. 6, Marcel Dekker , New York .
57. Moe , E. ( 1945 ), Overtraeking og Dragering , Dansk Farmaceutfoeningsverl ,
Copenhagen .
58. Hasegava , K. , Ida , T. , Saika , K. , and Utsumi , I. ( 1965 ), Suitable dimensions of tablets
for coating , Yakugaku Zasshi , 85 , 796 .
59. Selmeczi , B. , and Smogyi , J. ( 1996 ), Suitable dimensions of tablets for coating , Pharmacie
, 21 , 604 .
60. Bauer , K. H. , Fr ö mming , K. H. , and F ü hrer , C. ( 1993 ), Pharmazeutische Technologie
[Pharmaceutical Technology ], 4th ed. , Thieme , Stuttgart .
61. Bauer , K. H. , Lehmann , K. , Osterwald , H. P. , and Rothgang , G. ( 1998 ), Coated Pharmaceutical
Dosage Forms , Medpharm Scientifi c Publisher , Stuttgart .
62. B ü hler , V. ( 2003 , Sept.), Kollidon. Polyvinylpyrrolidone for the Pharmaceutical Industry
, 7th ed. , BASF Pharma Ingredients, Ludwigshafen , Germany .
63. U.S. Pharmacopeial Forum ( 2002 , May/June), Vol. 28. No. 3, 948 – 951.
64. Heng , P. W. S. , Wan , L. S. C. , and Tan , Y. T. F. ( 1996 ), Relationship between aggregation
of HPMC coated spheroids and tackiness/viscosity/additives of the coating formulations
, Int. J. Pharm. , 138 , 57 – 66 .
65. Tan , Y. T. F. , Wan , L. S. C. , and Heng , P. W. S. ( 1998 ), Evaluation of adhesion strength
measurement for predicting aggregation propensity during fl uidized bed coating , S.T.P.
Pharm. Sci. , 8 ( 3 ) 149 – 153 .
66. B ü hler , V. ( 2001 ), Generic Drug Formulation , 4th ed. , BASF Fine Chemicals, Ludwigshafen
, Germany .
67. Rowe , R. C. , and Forse , S. F. ( 1983 ), Pitting — A defect on fi lm - coated tablets , Int. J.
Pharm. , 17 ( 2 – 3 ), 347 – 349 .
68. Melgoza , L. M. , Caraballo , I. , Alvarez - Fuentes , J. , Millan , M. , and Rabasco , A. M.
( 1998 ), Study of morphine hydrochloride percolation threshold in Eudragit® RS - PM
matrices , Int. J. Pharm. , 170 , 169 – 177 .
69. Caraballo , I. , Melgoza , L. M. , Alvarez - Fuentes , J. , Soriano , M. C. , and Rabasco , A. M.
( 1999 ), Design of controlled release inert matrices of naltrexone hydrochloride based
on percolation concepts , Int. J. Pharm. , 181 , 23 – 30 .
70. Melgoza , L. M. , Rabasco , A. M. , Sandoval , H. , and Caraballo , I. ( 2001 ), Estimation of
the percolation thresholds in dextromethorphan hydrobromide matrices , Eur. J. Pharm.
Sci. , 12 ( 4 ), 453 – 459 .
71. Boza , A. , Blanquero , R. , Mill á n , M. , and Caraballo , I. ( 2004 ), Application of a new
mathematical method for the estimation of the mean surface area to calculate the percolation
threshold of Lobenzarit disodium salt in controlled release matrices , Chem.
Pharm. Bull. , 52 ( 7 ), 797 – 801 .
72. Reisine , T. , and Pasternak , G. ( 1996 ), Analg é sicos opioides y sus antagonistas , in
Goodman , A. , Hardman , J. G. , Limbird , L. E. , Molinoff , P. B. , and Ruddon , R. W. Eds.,
Las Bases Farmacol ó gicas de la Terap é utica , Vol. I, McGraw - Hill Interamericana , M é xico ,
pp. 557 – 593 .